Controlled trials in bipolar I depression: focus on switch rates and efficacy (Q33753303)

29 July 2017

1 reference

title

Controlled trials in bipolar I depression: focus on switch rates and efficacy (English)

1 reference

29 July 2017

J R Calabrese

1

1 reference

29 July 2017

D J Rapport

series ordinal

2

1 reference

29 July 2017

S E Kimmel

series ordinal

3

1 reference

29 July 2017

M D Shelton

series ordinal

4

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 August 1999

1 reference

European Neuropsychopharmacology

29 July 2017

1 reference

29 July 2017

9 Suppl 4

1 reference

29 July 2017

S109-12

1 reference

Antidepressant-induced mania and cycle acceleration: a controversy revisited

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900023-1

7 January 2021

Lithium carbonate response in depression. Prediction by unipolar/bipolar illness, average-evoked response, catechol-O-methyl transferase, and family history

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900023-1

7 January 2021

Lamotrigine and the treatment of mania in bipolar disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900023-1

7 January 2021

New concepts in mood stabilization: evidence for the effectiveness of valproate and lamotrigine.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900023-1

7 January 2021

A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900023-1

7 January 2021

A comparison of fluoxetine imipramine and placebo in patients with bipolar depressive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900023-1

7 January 2021

Prediction of antidepressant responses to lithium

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900023-1

7 January 2021

Outcome after rapid vs gradual discontinuation of lithium treatment in bipolar disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900023-1

7 January 2021

The Use of Lithium in Affective Disorders: I. Acute Endogenous Depression

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900023-1

7 January 2021

Lithium-carbonate treatment in depression and mania. A longitudinal double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900023-1

7 January 2021

Lithium Response in Unipolar Versus Bipolar Depression

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900023-1

7 January 2021

Catecholamine metabolism in affective disorders. 3. MHPG and other catecholamine metabolites in patients treated with lithium carbonate

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900023-1

7 January 2021

Tranylcypromine versus imipramine in anergic bipolar depression

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900023-1

7 January 2021

Lithium in the treatment of depression

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900023-1

7 January 2021

Lithium treatment of depression

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900023-1

7 January 2021

Antidepressant effects of carbamazepine

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900023-1

7 January 2021

Efficacy of lithium as acute treatment of manic-depressive illness

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900023-1

7 January 2021

Double-Blind Comparison of Lithium Carbonate and Imipramine in Treatment of Depression

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900023-1

7 January 2021

10.1016/S0924-977X(99)00023-1

Identifiers

DOI

1 reference

29 July 2017

1 reference